These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36387093)

  • 1. Impact of perioperative blood transfusion on long-term survival in patients with different stages of perihilar cholangiocarcinoma treated with curative resection:
    Liu ZP; Cheng ZJ; Dai HS; Zhong SY; Zhao DC; Gong Y; Zuo JH; Che XY; Chen WY; Wang ZR; Yu T; Cheng JJ; Liu XC; Bai J; Jiang Y; Zhang YQ; Lau WY; Deng SQ; Chen ZY
    Front Oncol; 2022; 12():1059581. PubMed ID: 36387093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perioperative blood transfusion does not influence recurrence-free and overall survivals after curative resection for hepatocellular carcinoma: A Propensity Score Matching Analysis.
    Yang T; Lu JH; Lau WY; Zhang TY; Zhang H; Shen YN; Alshebeeb K; Wu MC; Schwartz M; Shen F
    J Hepatol; 2016 Mar; 64(3):583-93. PubMed ID: 26596543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative blood transfusion does not affect recurrence-free and overall survivals after curative resection for intrahepatic cholangiocarcinoma: a propensity score matching analysis.
    Zhou PY; Tang Z; Liu WR; Tian MX; Jin L; Jiang XF; Wang H; Tao CY; Ding ZB; Peng YF; Qiu SJ; Dai Z; Zhou J; Fan J; Shi YH
    BMC Cancer; 2017 Nov; 17(1):762. PubMed ID: 29137600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of perioperative allogeneic blood transfusion on the long-term prognosis of patients with different stage tumors after radical resection for hepatocellular carcinoma.
    Peng T; Wang L; Cui H; Li X; Liu M; Yu J; Wu J; Zhao G; Liu Z
    Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):620-627. PubMed ID: 32988700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the prognostic value of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in perihilar cholangiocarcinoma patients following curative resection:
    Ge MY; Liu ZP; Pan Y; Wang JY; Wang X; Dai HS; Gao SY; Zhong SY; Che XY; Zuo JH; Liu YH; Liu XC; Fan HN; Chen WY; Wang ZR; Yin XY; Bai J; Zhang YQ; Jiang Y; Gong Y; Chen ZY
    Front Oncol; 2022; 12():1104810. PubMed ID: 36686802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Perioperative Blood Transfusion on the Postoperative Prognosis of Ruptured Hepatocellular Carcinoma Patients With Different BCLC Stages: A Propensity Score Matching Analysis.
    Xia F; Zhang Q; Huang Z; Ndhlovu E; Zhang M; Chen X; Zhang B; Zhu P
    Front Surg; 2022; 9():863790. PubMed ID: 35392056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a model based on the age-adjusted Charlson comorbidity index to predict survival for resected perihilar cholangiocarcinoma.
    Pan Y; Liu ZP; Dai HS; Chen WY; Luo Y; Wang YZ; Gao SY; Wang ZR; Dong JL; Liu YH; Yin XY; Liu XC; Fan HN; Bai J; Jiang Y; Cheng JJ; Zhang YQ; Chen ZY
    World J Gastrointest Oncol; 2023 Jun; 15(6):1036-1050. PubMed ID: 37389112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perioperative blood transfusion has distinct postsurgical oncologic impact on patients with different stage of hepatocellular carcinoma.
    Chen GX; Qi CY; Hu WJ; Wang XH; Hua YP; Kuang M; Peng BG; Li SQ
    BMC Cancer; 2020 May; 20(1):487. PubMed ID: 32471389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Validation of a Prognostic Model to Predict Recurrence-Free Survival After Curative Resection for Perihilar Cholangiocarcinoma: A Multicenter Study.
    Liu ZP; Chen WY; Wang ZR; Liu XC; Fan HN; Xu L; Pan Y; Zhong SY; Xie D; Bai J; Jiang Y; Zhang YQ; Dai HS; Chen ZY
    Front Oncol; 2022; 12():849053. PubMed ID: 35530316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival Impact of Perioperative Red Blood Cell Transfusion During Pancreatectomy in Patients With Pancreatic Ductal Adenocarcinoma: A Propensity Score Matching Analysis.
    Kitano Y; Yamashita YI; Matsumoto T; Kinoshita S; Itoyama R; Kaida T; Hayashi H; Imai K; Chikamoto A; Baba H
    Pancreas; 2022 Feb; 51(2):200-204. PubMed ID: 35404898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival analysis of patients with stage T2a and T2b perihilar cholangiocarcinoma treated with radical resection.
    Zhao J; Zhang W; Zhang J; Zhang Y; Ma WJ; Liu SY; Li FY; Song B
    BMC Cancer; 2020 Sep; 20(1):849. PubMed ID: 32883228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Body Mass Index on Tumor Recurrence in Patients Undergoing Liver Resection for Perihilar Cholangiocarcinoma (pCCA).
    Hau HM; Devantier M; Jahn N; Sucher E; Rademacher S; Seehofer D; Sucher R
    Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Impact of Perioperative CA19-9 Levels in Patients with Resected Perihilar Cholangiocarcinoma.
    Lee JW; Lee JH; Park Y; Kwon J; Lee W; Song KB; Hwang DW; Kim SC
    J Clin Med; 2021 Mar; 10(7):. PubMed ID: 33805079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of survival after surgery with curative intent for perihilar cholangiocarcinoma.
    Geers J; Jaekers J; Topal H; Aerts R; Vandoren C; Vanden Boer G; Topal B
    World J Surg Oncol; 2020 Nov; 18(1):286. PubMed ID: 33143698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perioperative blood transfusion has no effect on overall survival after esophageal resection for esophageal squamous cell carcinoma: A retrospective cohort study.
    Liu J; Chen S; Chen Y; Wang N; Ye X
    Int J Surg; 2018 Jul; 55():24-30. PubMed ID: 29578096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Surgical treatment for perihilar cholangiocarcinoma:a single-center experience].
    Deng WY; Shi XD; Ye YF; Tang QB; Lin HM; Yu XH; Liu C
    Zhonghua Wai Ke Za Zhi; 2023 Mar; 61(5):381-388. PubMed ID: 36987672
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of the short-term outcomes of robotic-assisted radical resection for perihilar cholangiocarcinoma: a propensity-scored matching analysis.
    Huang XT; Xie JZ; Cai JP; Chen W; Chen LH; Liang LJ; Yin XY
    Gastroenterol Rep (Oxf); 2023; 11():goad018. PubMed ID: 37051578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of the eighth AJCC/UICC staging system for perihilar cholangiocarcinoma: An alternative pathological staging system from cholangiocarcinoma-prevalent Northeast Thailand.
    Aphivatanasiri C; Sa-Ngiamwibool P; Sangkhamanon S; Intarawichian P; Kunprom W; Thanee M; Prajumwongs P; Khuntikeo N; Titapun A; Jareanrat A; Thanasukarn V; Srisuk T; Luvira V; Eurboonyanun K; Promsorn J; Loilome W; Wee A; Koonmee S
    Front Med (Lausanne); 2022; 9():893252. PubMed ID: 36250068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does perioperative allogeneic blood transfusion worsen the prognosis of patients with hepatocellular carcinoma? A meta-analysis of propensity score-matched studies.
    Hu L; Li Z; Qiao Y; Wang A
    Front Oncol; 2023; 13():1230882. PubMed ID: 37854678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of perioperative blood transfusion on oncological outcomes in ampullary carcinoma patients underwent pancreaticoduodenectomy.
    Fei H; Zhang XJ; Sun CY; Li Z; Li ZF; Guo CG; Zhao DB
    World J Gastrointest Surg; 2023 Jul; 15(7):1363-1374. PubMed ID: 37555106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.